Thomas Guldager Lauridsen

机构：Universidade Federal da Fronteira Sul

发表论文 52 篇 · 总被引 1044 次 · h-index 16

代表论文

• Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial (2022 · The Lancet · 被引 236)
• Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis (2022 · Diabetes Care · 被引 207)
• Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes (2023 · Annals of Internal Medicine · 被引 95)
• Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? A systematic review (2021 · BMC Nephrology · 被引 77)
• Estimation of renal perfusion based on measurement of rubidium-82 clearance by PET/CT scanning in healthy subjects (2021 · EJNMMI Physics · 被引 17)
• Bone Turnover, Mineralization, and Volume Estimated by 18F-Sodium Fluoride PET/CT and Biomarkers in Chronic Kidney Disease: Mineral and Bone Disorder Compared with Bone Biopsy (2022 · American Journal of Nephrology · 被引 16)